These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 18774706)

  • 21. Psychometric properties of the simplified Chinese version of the EORTC QLQ-BR53 for measuring quality of life for breast cancer patients.
    Wan C; Tang X; Tu XM; Feng C; Messing S; Meng Q; Zhang X
    Breast Cancer Res Treat; 2007 Oct; 105(2):187-93. PubMed ID: 17221159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of the EORTC QLQ-C30 and EORTC QLQ-H&N35 in patients with laryngeal cancer after surgery.
    Singer S; Wollbrück D; Wulke C; Dietz A; Klemm E; Oeken J; Meister EF; Gudziol H; Bindewald J; Schwarz R
    Head Neck; 2009 Jan; 31(1):64-76. PubMed ID: 18972411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaires for Arabic-speaking Populations.
    Awad MA; Denic S; El Taji H
    Ann N Y Acad Sci; 2008 Sep; 1138():146-54. PubMed ID: 18837895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Side-effects of treatment for localized prostate cancer: are they valued differently by patients and healthy controls?
    Korfage IJ; de Koning HJ; Habbema JD; Schröder FH; Essink-Bot ML
    BJU Int; 2007 Apr; 99(4):801-6. PubMed ID: 17233804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
    Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
    Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health-related quality of life 3 years after high-dose intensity-modulated radiotherapy with gold fiducial marker-based position verification.
    Lips IM; van Gils CH; van der Heide UA; Kruger AE; van Vulpen M
    BJU Int; 2009 Mar; 103(6):762-7. PubMed ID: 18990145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted-cryosurgical ablation of the prostate with androgen deprivation therapy: quality of life in high-risk prostate cancer patients.
    Kang SH; Kim JW; Bae JH; Park HS; Moon DG; Yoon DK; Cheon J; Kim JJ
    Asian J Androl; 2006 Sep; 8(5):629-36. PubMed ID: 16847531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of maximal androgen blockade in prostate cancer patients at a health area with type 2 reference hospital. Part 2. Quality of life: application of EORTC QLQ-PR25 instrument and global results. Quality-of-life adjusted survival. Pharmaceutical expenses and cost-utility.
    Guerra NA
    Arch Esp Urol; 2009 Sep; 62(7):543-70. PubMed ID: 19815968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The EORTC QLQ-C30 (version 3.0) Quality of Life questionnaire: validation study for Spain with head and neck cancer patients.
    Arraras JI; Arias F; Tejedor M; Pruja E; Marcos M; Martínez E; Valerdi J
    Psychooncology; 2002; 11(3):249-56. PubMed ID: 12112486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain.
    Fredheim OM; Borchgrevink PC; Saltnes T; Kaasa S
    J Pain Symptom Manage; 2007 Dec; 34(6):657-65. PubMed ID: 17618079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective analysis of results of p(65)+Be neutron therapy for treatment of prostate adenocarcinoma at the cyclotron of Louvain-la-Leuve. Part II: Side effects and their influence on quality of life measured with QLQ-C30 of EORTC.
    Scalliet PG; Remouchamps V; Curran D; Ledent G; Wambersie A; Richard F; van Cangh P
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1549-61. PubMed ID: 15050336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promising long-term health-related quality of life after high-dose-rate brachytherapy boost for localized prostate cancer.
    Wahlgren T; Nilsson S; Lennernäs B; Brandberg Y
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):662-70. PubMed ID: 17499452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health-related quality-of-life in patients with head-and-neck cancer in Sri Lanka: psychometric properties of the 'Sinhala' version of the EORTC QLQ-H&N35.
    Jayasekara H; Rajapaksa LC; Aaronson NK
    Psychooncology; 2009 Oct; 18(10):1116-21. PubMed ID: 19142857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of high dose rate brachytherapy in combination with external beam radiotherapy on men's health-related quality of life and sexual function over a 2 year time span.
    Conaglen HM; de Jong D; Hartopeanu C; Conaglen JV; Tyrie LK
    Clin Oncol (R Coll Radiol); 2013 Mar; 25(3):197-204. PubMed ID: 23183305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impacts of leuprolide acetate on quality of life in patients with prostate cancer: a prospective multicenter study.
    You D; Jeong IG; Kim SW; Chung BH; Cho JS; Lee HM; Yun SC; Kim CS
    Scand J Urol Nephrol; 2010 Dec; 44(6):399-405. PubMed ID: 20707648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Translation and validation of the EORTC QLQ-C30 for use among Turkish and Moroccan ethnic minority cancer patients in the Netherlands.
    Hoopman R; Muller MJ; Terwee CB; Aaronson NK
    Eur J Cancer; 2006 Aug; 42(12):1839-47. PubMed ID: 16750911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychometric evaluation of the Taiwan Chinese version of the EORTC QLQ-PR25 for HRQOL assessment in prostate cancer patients.
    Chang YJ; Liang WM; Wu HC; Lin HC; Wang JY; Li TC; Yeh YC; Chang CH
    Health Qual Life Outcomes; 2012 Aug; 10():96. PubMed ID: 22901052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective quality of life study in patients with locally advanced prostate cancer, treated with radiotherapy with or without regional or interstitial hyperthermia.
    Van Vulpen M; De Leeuw JR; Van Gellekom MP; Van Der Hoeven J; De Graeff A; Van Moorselaar RJ; Van Der Tweel I; Hofman P; Lagendijk JJ; Battermann JJ
    Int J Hyperthermia; 2003; 19(4):402-13. PubMed ID: 12850926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The European Organization for Research and Treatment of Cancer core quality of life questionnaire (QLQ-C30 version 3.0 Turkish) in cancer patients receiving palliative radiotherapy.
    Hiçsönmez A; Köse K; Andrieu MN; Güney Y; Kurtman C
    Eur J Cancer Care (Engl); 2007 May; 16(3):251-7. PubMed ID: 17508945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health-related quality of life in Dutch men with prostate cancer.
    Voerman B; Fischer M; Visser A; Garssen B; van Andel G; Bensing J
    J Psychosoc Oncol; 2006; 24(2):49-64. PubMed ID: 17046806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.